Description
This award has been established by the American Association for Cancer Research and Eli Lilly and Company to acknowledge and catalyze the growing importance of interdisciplinary teams to the understanding of cancer and/or the translation of research discoveries into clinical cancer applications. Proactive interaction between academic and industry researchers is particularly crucial to continue progress and accelerate drug development.
Prize
Varies
Timing
Annual
Notes
In the case of unlimited submission prizes, nominators do not need to go through the Dean of the Faculty of Medicine's office.